NCT07220213

FELLAShip to Better Health

Recruiting now NA Last updated 22 January 2026

What this trial tests

NA trial testing FELLAship in High Blood Glucose in 90 participants. Currently enrolling.

Timeline

1 January 2026

Primary endpoint
1 January 2027

1 January 2027

Quick facts

Lead sponsor	University of Alabama at Birmingham
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	prevention
Enrollment	90
Start date	1 January 2026
Primary completion	1 January 2027
Estimated completion	1 January 2027
Sites	1 location across United States

Drugs / interventions tested

• FELLAship

Conditions studied

• High Blood Glucose — all drugs for High Blood Glucose →
• High Cholesterol — all drugs for High Cholesterol →
• High Cholesterol/Hyperlipidemia — all drugs for High Cholesterol/Hyperlipidemia →
• Blood Sugar; High — all drugs for Blood Sugar; High →

Sponsor

University of Alabama at Birmingham

Who can join

18 and older, male only, with High Blood Glucose or High Cholesterol. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to evaluate the implementation and effectiveness of the FELLAship program-a church-based cardiovascular health (CVH) intervention-in Black men aged 35-70 who are at risk for heart disease, diabetes, obesity, and related conditions. The main questions this study aims to answer are:

* Does participation in the FELLAship program improve cardiovascular health metrics (e.g., blood pressure, cholesterol, blood sugar) and health behaviors among Black men at The Worship Center Christian Church (TWC)?
* What factors influence the adoption, delivery, and sustainability of the FELLAship program in a faith-based setting? Researchers will compare an immediate-start intervention group and a delayed-start (waitlist control) group to assess both short-term health outcomes and program implementation factors.

Participants will:

* Attend a 90-minute weekly session for 24 weeks, including 45 minutes of physical activity led by a certified trainer and 45 minutes of health education delivered by trained coaches.
* Receive one-on-one support from a community health worker to reduce barriers to care and engage with primary care.
* Complete biometric health screenings and surveys at baseline, 12 weeks, and 24 weeks to assess clinical and behavioral outcomes.
* Use a smartwatch, blood pressure cuff, and other tools to track progress in real time.
* Participate in exit focus groups or interviews to share feedback about the intervention.
* A subset of TWC leaders and interventionists (N=15) will also be interviewed to assess implementation, resource needs, and sustainability.

This study uses the RE-AIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance) framework to assess Reach, Effectiveness, Adoption, Implementation, and Maintenance, and aims to inform scalable strategies for improving CVH among Black men in trusted community settings.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.